Given its emergent role in osteoblast differentiation and bone development, ZNF687 could represent a promising target for therapeutic purposes in human bone-related disorders, characterized by defective (e.g., osteoporosis and osteopenia) or excessive bone formation (e.g., osteopetrosis and PDB). Here, ZNF687 is linked to osteoporosis.